(CCAP) Crescent Capital BDC - Overview
Sector: Financial Services | Industry: Asset Management | Exchange: NASDAQ (USA) | Market Cap: 410m USD | Total Return: -16% in 12m
Avg Turnover: 2.29M
EPS Trend: -74.2%
Qual. Beats: 0
Rev. Trend: -4.8%
Qual. Beats: -1
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
Crescent Capital BDC, Inc. (CCAP) is a business development company (BDC) focused on direct investments within the U.S. middle market. The firm primarily engages in private equity buyouts and the provision of specialized loan products to established mid-sized enterprises.
Operating under the Investment Company Act of 1940, BDCs like CCAP are required to distribute at least 90% of their taxable income to shareholders to maintain their tax-advantaged status. This business model focuses on generating income through senior secured debt and equity co-investments, typically targeting companies with resilient cash flows. For those analyzing dividend sustainability and portfolio composition, further data is available on ValueRay.
- Net interest margin expansion driven by floating rate senior secured loan portfolio
- Middle market credit quality stability amid tightening monetary policy and economic cycles
- Strategic acquisition of First Eagle BDC expands asset base and scale
- Dividend coverage ratios supported by consistent fee income and investment yields
- Potential credit losses in sponsor-backed portfolio companies impact net asset value
| Net Income: 15.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 2.20 > 1.0 |
| NWC/Revenue: 0.91% < 20% (prev 11.89%; Δ -10.98% < -1%) |
| CFO/TA 0.05 > 3% & CFO 87.8m > Net Income 15.1m |
| Net Debt (880.5m) to EBITDA (78.2m): 11.26 < 3 |
| Current Ratio: 1.03 > 1.5 & < 3 |
| Outstanding Shares: last quarter (36.9m) vs 12m ago -0.37% < -2% |
| Gross Margin: 66.90% > 18% (prev 0.51%; Δ 6.64k% > 0.5%) |
| Asset Turnover: 7.60% > 50% (prev 7.11%; Δ 0.49% > 0%) |
| Interest Coverage Ratio: 1.28 > 6 (EBITDA TTM 78.2m / Interest Expense TTM 53.8m) |
| A: 0.00 (Total Current Assets 37.5m - Total Current Liabilities 36.4m) / Total Assets 1.62b |
| B: -0.17 (Retained Earnings -282.0m / Total Assets 1.62b) |
| C: 0.04 (EBIT TTM 68.7m / Avg Total Assets 1.64b) |
| D: -0.30 (Book Value of Equity -282.0m / Total Liabilities 943.6m) |
| Altman-Z'' = -0.60 = B |
As of May 24, 2026, the stock is trading at USD 11.44 with a total of 214,002 shares traded.
Over the past week, the price has changed by +2.16%,
over one month by -13.86%,
over three months by -9.20% and
over the past year by -16.01%.
Crescent Capital BDC has received a consensus analysts rating of 4.17. Therefore, it is recommended to buy CCAP.
- StrongBuy: 3
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 14.2 | 23.9% |
P/E Forward = 8.2102
P/S = 2.5149
P/B = 0.7095
P/EG = 0.8918
Revenue TTM = 124.8m USD
EBIT TTM = 68.7m USD
EBITDA TTM = 78.2m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 907.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 880.5m USD (calculated: Debt 907.1m - CCE 26.6m)
Enterprise Value = 1.29b USD (410.1m + Debt 907.1m - CCE 26.6m)
Interest Coverage Ratio = 1.28 (Ebit TTM 68.7m / Interest Expense TTM 53.8m)
EV/FCF = 19.54x (Enterprise Value 1.29b / FCF TTM 66.1m)
FCF Yield = 5.12% (FCF TTM 66.1m / Enterprise Value 1.29b)
FCF Margin = 52.94% (FCF TTM 66.1m / Revenue TTM 124.8m)
Net Margin = 12.10% (Net Income TTM 15.1m / Revenue TTM 124.8m)
Gross Margin = 66.90% ((Revenue TTM 124.8m - Cost of Revenue TTM 41.3m) / Revenue TTM)
Gross Margin QoQ = 74.64% (prev 80.64%)
Tobins Q-Ratio = 0.80 (Enterprise Value 1.29b / Total Assets 1.62b)
Interest Expense / Debt = 5.93% (Interest Expense 53.8m / Debt 907.1m)
Taxrate = 4.65% (1.68m / 36.2m)
NOPAT = 65.5m (EBIT 68.7m * (1 - 4.65%))
Current Ratio = 1.03 (Total Current Assets 37.5m / Total Current Liabilities 36.4m)
Debt / Equity = 1.35 (Debt 907.1m / totalStockholderEquity, last quarter 674.0m)
Debt / EBITDA = 11.26 (Net Debt 880.5m / EBITDA 78.2m)
Debt / FCF = 13.33 (Net Debt 880.5m / FCF TTM 66.1m)
Total Stockholder Equity = 704.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.92% (Net Income 15.1m / Total Assets 1.62b)
RoE = 1.53% (Net Income TTM 15.1m / Total Stockholder Equity 986.8m)
RoCE = 4.35% (EBIT 68.7m / Capital Employed (Total Assets 1.62b - Current Liab 36.4m))
RoIC = 4.22% (NOPAT 65.5m / Invested Capital 1.55b)
WACC = 6.72% (E(410.1m)/V(1.32b) * Re(9.06%) + D(907.1m)/V(1.32b) * Rd(5.93%) * (1-Tc(0.05)))
Discount Rate = 9.06% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -81.65 | Cagr: -0.31%
[DCF] Terminal Value 77.97% ; FCFF base≈52.2m ; Y1≈59.9m ; Y5≈88.1m
[DCF] Fair Price = 12.08 (EV 1.33b - Net Debt 880.5m = Equity 445.0m / Shares 36.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -74.16 | EPS CAGR: -9.26% | SUE: 0.09 | # QB: 0
Revenue Correlation: -4.80 | Revenue CAGR: -1.17% | SUE: -0.84 | # QB: -1
EPS current Quarter (2026-06-30): EPS=0.36 | Chg30d=-10.85% | Revisions=+43% | Analysts=5
EPS next Quarter (2026-09-30): EPS=0.38 | Chg30d=-8.29% | Revisions=+43% | Analysts=5
EPS current Year (2026-12-31): EPS=1.54 | Chg30d=-5.77% | Revisions=+25% | GrowthEPS=-14.7% | GrowthRev=-10.7%
EPS next Year (2027-12-31): EPS=1.49 | Chg30d=-3.86% | Revisions=+0% | GrowthEPS=-3.6% | GrowthRev=-2.1%
[Analyst] Revisions Ratio: +43%